This Gene Therapy Can Restore Vision, but Will It Break the Bank? – Motley Fool
Madison.com |
This Gene Therapy Can Restore Vision, but Will It Break the Bank?
Motley Fool Luxturna is a gene therapy to treat patients with vision loss from biallelic RPE65 mutation-associated retinal dystrophy. It's administered by subretinal injection, and in trials, it's been shown to restore vision in more than 90% of patients for up to … Spark gene therapy for blindness could come at steep cost |
